{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:29:08Z","timestamp":1695706148630},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Primary neuroendocrine tumor of the mediastinum is a relatively rare entity. In metastatic\/inoperable disease, therapeutic options are limited to cytotoxic chemotherapy in poorly differentiated tumors and peptide receptor radionuclide therapy in case of well-differentiated tumors. We present the case of a 52-year-old man with mediastinal atypical carcinoid (grade II) neuroendocrine tumor showing mild somatostatin receptor expression and intense FDG avidity with progressive disease on chemotherapy. Chemokine receptor targeted PET\/CT with CXCR4 (<jats:sup>68<\/jats:sup>Ga-CXCR4) showed tracer avidity in tumor sites higher than the physiological sites, which may pave the way for CXCR4-targeted radionuclide therapy in this subgroup of patients.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003177","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:21:55Z","timestamp":1601500915000},"page":"e422-e424","source":"Crossref","is-referenced-by-count":0,"title":["Expression of CXCR4 Receptors in Refractory Atypical Mediastinal Carcinoid"],"prefix":"10.1097","volume":"45","author":[{"given":"Venkata Subramanian","family":"Krishnaraju","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swayamjeet","family":"Satapathy","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan Krushna","family":"Das","sequence":"additional","affiliation":[{"name":"Regional Cancer Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Histopathology, PGIMER, Chandigarh, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"issue":"suppl 115","key":"bib1-20230925","first-page":"S17","article-title":"Neuroendocrine neoplasms of the mediastinum","volume":"115","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1378\/chest.128.4.2893","article-title":"Tumors of the mediastinum","volume":"128","year":"2005","journal-title":"Chest"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MNM.0000000000000985","article-title":"Comparison of (18F)FDG PET\/CT and (68Ga)DOTATATE PET\/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors","volume":"40","year":"2019","journal-title":"Nucl Med Commun"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/cancers10120510","article-title":"Management of typical and atypical pulmonary carcinoids based on different established guidelines","volume":"10","year":"2018","journal-title":"Cancers (Basel)"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/02841860500544909","article-title":"Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma","volume":"45","year":"2006","journal-title":"Acta Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","year":"2006","journal-title":"Blood"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymeth.2017.09.002","article-title":"Chemokine receptor\u2013directed imaging and therapy","volume":"130","year":"2017","journal-title":"Methods"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.7150\/thno.18754","article-title":"Imaging of chemokine receptor 4 expression in neuroendocrine tumors\u2014a triple tracer comparative approach","volume":"7","year":"2017","journal-title":"Theranostics"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:09:01Z","timestamp":1695622141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003177","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}